(Louis) My Reading and Writing, Unit 2, Many Kinds of Characters (Large Print)
by American Printing House for the Blind
Last verified July 3, 2026 · classified July 5, 2026
What it is
Summary
AI-generated from vendor-published content · July 5, 2026
This is the large-print edition of Unit 2 from APH's 'My Reading and Writing' series, titled 'Many Kinds of Characters' — a literacy curriculum workbook adapted for students with low vision. The oversized text and high-contrast formatting allow students who can't access standard print to participate in the same reading and writing skill-building activities as their sighted peers. It's part of a multi-unit series, so it fits into a broader classroom or intervention sequence rather than functioning as a standalone program. This specific unit is Federal Quota eligible, meaning schools can use APH quota funds to obtain it at no direct cost — a meaningful consideration for school budgets.
Quick Facts Catalog facts · auto-generated
- Out of pocket
- School district
What Setup Looks Like
- Out of the box
Student opens the workbook and begins reading and completing activities in the large-print format — no setup required. - With professional help
- A teacher of students with visual impairments (TVI) or special education teacher should select appropriate units based on the student's reading level and IEP goals.
- Coordinate with the school's APH quota coordinator to order through Federal Quota funding if applicable.
Getting it
Many states lend devices like this for free trial periods — find your state's AT lending program.
Where to Get It
Some links may be affiliate links — WhatCanHelp may earn a small commission from purchases at no extra cost to you. More on affiliates →
Wondering how equipment like this gets paid for? See the official funding programs in your state.
Compare & explore
Sources & fine print
Vendor facts (name, price, platforms, vendor link) sourced from American Printing House for the Blind — view on vendor site; last verified July 3, 2026.
Classification & description AI-generated from vendor-published content on July 5, 2026 · confidence: high. Vendor specs may lag; verify before relying on details in a clinical or funding artifact.